1. Sallan SE, Zinberg NE and Frei E: Antiemetic effect of delta-9-tetrahydrocannabinol in patients receiving cancer chemotherapy.  New Eng J Med 1975;293:795-97
  2. Anderson PO, McGuire CG: Delta-9-tetrahydrocannabinol as an antiemetic.  Am J Hosp Pharm 1981;38:639-46
  3. Poster DS, Penta JS, Bruno S et al: Delta-9-tetrahydrocannabinol in clinical oncology.  JAMA 1981;245:2047-2051
  4. Cocchetto DM, Cook LF, Cato AE: A critical review of the safety and antiemetic efficacy of delta-9-tetrahydrocannabinol.  Drug Intell Clin Pharm 1981;15:867-75
  5. Gralia RJ, Tyson LB, Bordin LA et al: Antiemetic therapy: A review of recent studies and a report of a random assignment trial comparing metachlopramide with delta-9-tetrahydrocannabinol.  Cancer Treat Repts 1984;68:163-172
  6. Vincent BJ, McQuiston DJ, Einhorn LH et al: Review of cannabinoids and their antiemetic effectiveness.  Drugs 1983 (Suppl 1);25:52-62
  7. Carey MP, Burish TG, Brenner DE: Delta-9-tetrahydrocannabinol in cancer chemotherapy: Research problems and issues.  Ann Int Med 1983;99:106-114
  8. Olver IN, Simon RM, Aisner J: Antiemetic studies: A methodological discussion.  Cancer Treat Repts 1986;70:555-563
  9. DeRogatis LR: SCL-90-R Administration, Scoring and Procedures Manual for the Revised Version.  Baltimore, MD, John Hopkins University, 1978
  10. Kellner R: Target Problem Self-Rating Scale.  Albuquerque, NM, University of New Mexico, 1978
  11. Lipman RS, Cole JO, Park LC, et al: Sensitivity of symptom and non-symptom focused criteria of outpatient drug efficacy.  Am J Psychiat 1965;122:24-27
  12. Park LC, Uhlenhuth EH, Lipman RS, et al: A comparison of doctor and patient improvement ratings in a drug (meprobamate) trial.  Brit J Psychiat 1965;111:535-540
  13. Battle CC, Imber SD, Hoen-Saric R, et al: Target complaints as criteria of improvement.  Am J Psychother 1965;20:184-192
  14. Freyhan, FA: Therapeutic implications of differential effects of new phenothiazine compounds.  Am J Psychiat 1959;115:577-587
  15. Cadman E: Toxicity of Chemotherapeutic Agents, In Becker FB (Ed) Cancer: A Comprehensive Treatise-Vol 5, New York, Plenum Press, 1977, pp59-111
  16. Drapkin RL: Management of Chemotherapy-induced nausea and vomiting.  In Wiernik PH (Ed) Mediguide to Oncology, Vol 2, No 5, New York, Lawrence Delia Corte Publication, 1982
  17. Stevens JP: Power of the multivariate analysis of variance tests.  Psychol Bull 1980;88:728-737
  18. Cohen J: Statistical Power Analysis for the Behavioral Sciences. Revised Edition.  New York, Academic Press, 1977

Return to Report

Bryan A. Krumm
New Mexicans for Compassionate Use
phone (505) 286-1325
P.O.Box 4241
Albuquerque, N.M. 87196-4241